Abstract:Background Autism spectrum disorder (ASD) is a lifelong condition. It is characterized by complex etiologies, including disruptions in exogenous retinoic acid (RA) signaling, which may serve as an environmental risk factor. Targeting the RA pathway presents a promising therapeutic avenue, though the precise mechanisms remain to be elucidated. Methods Female Sprague–Dawley rats were treated with valproic acid (VPA) during pregnancy to induce an ASD model in their offspring. Some offspring received RA treatment postnatally. Social behavior and brain-functional connectivity were assessed using behavioral tests and functional magnetic resonance imaging (fMRI), respectively. Transcriptomics analysis and proteomics analysis of the hypothalamus identified differentially expressed genes (DEGs) and differentially expressed proteins (DEPs). These were intersected with ASD pathogenic genes (APGs) and ASD pathogenic proteins (APPs) to identify differentially expressed APGs (DE-APGs) and differentially expressed APPs (DE-APPs), which were validated by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. Analyses of enrichment of signaling pathways were done using the Kyoto Encyclopedia of Genes and Genomes database. Results RA treatment significantly improved social behaviors and revealed distinct patterns of hypo- and hyper-connectivity across various brain regions, with notable changes involving the hypothalamus and facial nerve. Differential analysis revealed 4165 DEGs (DEG 1) and 329 DEPs (DEP 1) between control and VPA groups, and 1610 DEGs (DEG 2) and 197 DEPs (DEP 2) between VPA and RA supplementation (RAS) groups. Twenty-two DE-APGs and five DE-APPs were identified, with key associations found between proteins such as Tbl1xr1 and Myo5a and >13 genes including Nrxn1, Cacna1e, and Gabrb2. Significant alterations in DE-APGs, including Grin2b, Nrxn1, Cacna1e, and Gabrb2, were confirmed via real-time RT-PCR and western blotting. In addition, 22 key signaling pathways were enriched in DEPs and DEGs. Conclusion RA supplementation in ASD rats induced by VPA may ameliorate social deficits and modulated functional connectivity, especially in the hypothalamus and facial nerve regions. This suggests potential therapeutic benefits for neural circuitry dysregulation in ASD. Additionally, RA altered critical gene and protein expressions in hypothalamus, implicating its role in modulating key signaling pathways to mitigate social deficits in ASD. This study provides new insights into the molecular mechanisms of ASD and supports the development of novel therapeutic strategies.

Excessive UBE3A Dosage Impairs Retinoic Acid Signaling and Synaptic Plasticity in Autism Spectrum Disorders

UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies

mRNA nuclear retention reduces AMPAR expression and promotes autistic behavior in UBE3A-overexpressing mice

Sexually dimorphic phenotypes and the role of androgen receptors in UBE3A-dependent autism spectrum disorder

The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization Via Caspase-Dependent Microtubule Destabilization

Epilepsy-Associated UBE3A Deficiency Downregulates Retinoic Acid Signalling Pathway

Sex-biasing influence of autism-associated Ube3a gene overdosage at connectomic, behavioral, and transcriptomic levels

UBE3A-mediated PTPA Ubiquitination and Degradation Regulate PP2A Activity and Dendritic Spine Morphology.

The role of glia in the dysregulation of neuronal spinogenesis in Ube3a-dependent ASD

Glutaminase 1 Deficiency Confined in Forebrain Neurons Causes Autism Spectrum Disorder-Like Behaviors.

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Synaptic P-Rex1 Signaling Regulates Hippocampal Long-Term Depression and Autism-Like Social Behavior.

Mechanistic Insights into Retinoic-Acid Treatment for Autism in the Improvement of Social Behavior: Evidence from a Multi Omics Study in Rats

Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice

Blood Exosome Sensing Via Neuronal Insulin-Like Growth Factor-1 Regulates Autism-Related Phenotypes.

Untargeted Metabolomic Analysis Reveals the Metabolic Disturbances and Exacerbation of Oxidative Stress in the Cerebral Cortex of a BTBR Mouse Model of Autism

Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations

Retinoic acid supplementation ameliorates motor incoordination via RARα-CBLN2 in the cerebellum of a prenatal valproic acid-exposed rat autism model

Retinoic Acid Supplementation Rescues the Social Deficits in Fmr1 Knockout Mice

Targeting histone demethylase LSD1 for treatment of deficits in autism mouse models

Role of the DUB Enzyme USP7 in Dendritic Arborization, Neuronal Migration, and Autistic-Like Behaviors in Mice